| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/20/2007 | US20070293484 Thiophene Heteroaryl Amines |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293447 Gene Therapy for Skin Disorders Using Needleless Syringes |
| 12/20/2007 | US20070293433 Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion |
| 12/20/2007 | US20070292530 Topical composition and method for the treatment and prophylaxis of dermal irritations |
| 12/20/2007 | US20070292461 Oleaginous pharmaceutical and cosmetic foam |
| 12/20/2007 | US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/20/2007 | US20070292359 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof |
| 12/20/2007 | US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions |
| 12/19/2007 | EP1867343A2 Novel compounds |
| 12/19/2007 | EP1867322A1 Topical composition for the treatment of psoriasis |
| 12/19/2007 | EP1866033A1 Sunscreen aerosol spray |
| 12/19/2007 | EP1865982A1 Hydrogel composition for modulation of topical inflammatory response |
| 12/19/2007 | EP1865975A2 Compositions containing cotinus coggygria extract and use thereof on mucosal tissues |
| 12/19/2007 | EP1865968A2 Topical formulations of borinic acid antibodies and their methods of use |
| 12/19/2007 | EP1865964A1 Topical formulations for use in the treatment or prevention of dermatological conditions |
| 12/19/2007 | EP1865957A2 Method of treating actinic keratosis |
| 12/19/2007 | EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer |
| 12/19/2007 | EP1865953A2 Composition comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof |
| 12/19/2007 | EP1865950A1 Compounds useful as modulators of the proteasome activity |
| 12/19/2007 | EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders |
| 12/19/2007 | EP1546152B1 Epothilone derivatives |
| 12/19/2007 | EP1503757B1 Tyrosine kinase inhibitors |
| 12/19/2007 | EP1497261B1 Phenethanolamine derivatives |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1422224B1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 12/19/2007 | EP1411921B1 Pharmaceutical compositions containing terbinafine and use thereof |
| 12/19/2007 | EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists |
| 12/19/2007 | EP1335719B1 Cetyl myristate and cetyl palmitate for treating eczema and/or psoriasis |
| 12/19/2007 | EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 12/19/2007 | EP1100432B1 Novel uses of ascorbyl-phosphoryl-cholesterol and compositions for practicing same |
| 12/19/2007 | EP1005341B1 Il-8 receptor antagonists |
| 12/19/2007 | CN101090727A Intraoral disintegration type solid preparation containing povidone iodine |
| 12/19/2007 | CN101090725A Pharmaceutical composition comprising an ointment and two solubilized active principles |
| 12/19/2007 | CN101090705A Composition for improving hair growth comprising an non-polar solvent-soluble extract of cantharis as an active ingredient |
| 12/19/2007 | CN101090643A Temporally meal menu for infants |
| 12/19/2007 | CN101088554A Psoriasis treating Chinese medicine composition and its prepn process |
| 12/19/2007 | CN101088553A Effective part of seesile stemona alkaloid and its application |
| 12/19/2007 | CN101088552A Psoriasis treating method |
| 12/19/2007 | CN101088487A Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355748C Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355437C Medicine for treating scald and burn and preparing method |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309710 Crystals |
| 12/18/2007 | US7309689 Sustained peptide-release formulation |
| 12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 12/18/2007 | CA2489763C Pharmaceutical salts of reboxetine |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
| 12/18/2007 | CA2325497C Dietary supplement for preventing or reducing shedding of hair |
| 12/18/2007 | CA2233042C Specific binding members for human transforming growth factor beta; materials and methods |
| 12/18/2007 | CA2103306C Extrudable compositions for topical or transdermal drug delivery |
| 12/13/2007 | WO2007143002A2 Nutraceutical treatments for diabetic and non-diabetic wound healing |
| 12/13/2007 | WO2007142942A2 Method of improving wound healing |
| 12/13/2007 | WO2007142349A1 Hair growth composition |
| 12/13/2007 | WO2007142325A1 Preventive or remedy for inflammatory disease |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007142158A1 9,10-secopregnane derivative and pharmaceutical |
| 12/13/2007 | WO2007142130A1 Maitake mushroom extract and composition for enhancing the production of sebum comprising the extract |
| 12/13/2007 | WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food |
| 12/13/2007 | WO2007141224A2 Jnk inhibitors for treatment of skin diseases |
| 12/13/2007 | WO2007140791A1 Treatment of cutaneous neurogenic inflammation |
| 12/13/2007 | WO2007098106A3 Respiratory tract delivery of interferon-tau |
| 12/13/2007 | US20070287949 Transdermal System for Sustained Delivery of Polypeptides |
| 12/13/2007 | US20070287733 Method of Treating Skin Diseases |
| 12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287689 Therapeutic And/Or Preventive Agents For Chronic Skin Diseases |
| 12/13/2007 | US20070287688 Pharmaceutical Compositions for Topical Application |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286915 Nerve Growth Factor Production Inhibitor and External Preparation for the Skin, Cosmetic, Quasi Drug, Preventive and Remedy for Atopic Dermatitis Containing the Nerve Growth Factor Production Inhibitor |
| 12/13/2007 | US20070286876 Skin care compositions comprising low concentrations of skin treatment agents |
| 12/13/2007 | US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis |
| 12/13/2007 | US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1) |
| 12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
| 12/13/2007 | US20070286848 Epas1 Gene Transfer to Improve Cell Therapy |
| 12/13/2007 | US20070286845 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 12/13/2007 | DE202004021321U1 Verwendung eines Extraktes von Aloysia triphylla Use of an extract of Aloysia triphylla |
| 12/13/2007 | CA2657590A1 Treatment of excess sebum production |
| 12/13/2007 | CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease |
| 12/13/2007 | CA2653772A1 9,10-secopregnane derivative and pharmaceutical |
| 12/13/2007 | CA2636288A1 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 12/12/2007 | EP1864992A2 Monosaccharide derivatives |
| 12/12/2007 | EP1864986A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 12/12/2007 | EP1864977A1 Novel cyclic compound having pyrimidinylalkylthio group |
| 12/12/2007 | EP1864975A2 Novel compounds |
| 12/12/2007 | EP1864675A1 Orally administered peptides to ameliorate atherosclerosis |
| 12/12/2007 | EP1864665A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient |
| 12/12/2007 | EP1864657A1 Treatment of cutaneous neurogenic inflammation |
| 12/12/2007 | EP1863519A1 Monitoring and modulating hgf/hgfr activity |
| 12/12/2007 | EP1863502A2 Method of treating skin ulcers using oxidative reductive potential water solution |
| 12/12/2007 | EP1863501A2 Method of treating second and third degree burns using oxidative reductive potential water solution |
| 12/12/2007 | EP1863493A1 Corticosteroid containing formulation for treating psoriasis, eczema, ulcer and burns. |
| 12/12/2007 | EP1863469A1 A topical analgesic composition |
| 12/12/2007 | EP1863468A1 A topical anaesthetic composition |